The Competition Appellate Tribunal (CAT) upheld a previous decision by the (CCP), which found Reckitt Benckiser Pakistan Limited guilty of deceptive marketing practices. The company was accused of misleading consumers about the product’s status, specifically regarding its classification as medicinal or non-medicated.
Reckitt Benckiser has been ordered to pay a penalty of Rs30 million for violating Section 10(2)(b) of the Competition Act, 2010. This act prohibits disseminating misleading information about products’ nature and character.
The Tribunal noted that Reckitt Benckiser had introduced changes to its product’s packaging and disclosures following CCP proceedings. These changes included prominently displaying “Non-Medicated” in English and Urdu on the packaging and blister packs.
As part of the corrective measures, the company must also publicize these changes through advertisements in widely circulated newspapers across Pakistan until full compliance is achieved. This recovery underscores CCP’s commitment to protecting consumer interests and ensuring transparency in marketing practices.
foodpanda, Pakistan’s leading online delivery platform, has announced a massive Rider Recruitment Drive in Karachi…
Meezan Bank has advised the Government of Pakistan on the successful issuance of the country’s…
Pakistan Mercantile Exchange Limited (PMEX), Pakistan’s only regulated commodity futures exchange, has launched a nationwide…
Some voices stay with people long after the song ends. For more than two decades,…
Business confidence in Pakistan recovered during the second quarter of 2026, with companies reporting improved…
Karachi, 22 July: Master Auto Engineering (MAE), a company of Master Group of Industries and…
This website uses cookies.
